1. Home
  2. CYCC vs GCTS Comparison

CYCC vs GCTS Comparison

Compare CYCC & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • GCTS
  • Stock Information
  • Founded
  • CYCC 1992
  • GCTS 1998
  • Country
  • CYCC Malaysia
  • GCTS United States
  • Employees
  • CYCC N/A
  • GCTS N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • GCTS Blank Checks
  • Sector
  • CYCC Health Care
  • GCTS Finance
  • Exchange
  • CYCC Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • CYCC 61.2M
  • GCTS 69.0M
  • IPO Year
  • CYCC N/A
  • GCTS N/A
  • Fundamental
  • Price
  • CYCC $1.63
  • GCTS $1.03
  • Analyst Decision
  • CYCC
  • GCTS Strong Buy
  • Analyst Count
  • CYCC 0
  • GCTS 1
  • Target Price
  • CYCC N/A
  • GCTS $5.00
  • AVG Volume (30 Days)
  • CYCC 191.0K
  • GCTS 692.1K
  • Earning Date
  • CYCC 05-15-2025
  • GCTS 05-14-2025
  • Dividend Yield
  • CYCC 147.24%
  • GCTS N/A
  • EPS Growth
  • CYCC N/A
  • GCTS N/A
  • EPS
  • CYCC N/A
  • GCTS N/A
  • Revenue
  • CYCC $14,000.00
  • GCTS $6,359,000.00
  • Revenue This Year
  • CYCC $137.21
  • GCTS $315.43
  • Revenue Next Year
  • CYCC N/A
  • GCTS $170.52
  • P/E Ratio
  • CYCC N/A
  • GCTS N/A
  • Revenue Growth
  • CYCC N/A
  • GCTS N/A
  • 52 Week Low
  • CYCC $1.36
  • GCTS $1.01
  • 52 Week High
  • CYCC $49.34
  • GCTS $5.65
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 32.89
  • GCTS 36.50
  • Support Level
  • CYCC $1.36
  • GCTS $1.01
  • Resistance Level
  • CYCC $1.94
  • GCTS $1.10
  • Average True Range (ATR)
  • CYCC 0.43
  • GCTS 0.21
  • MACD
  • CYCC -0.07
  • GCTS -0.03
  • Stochastic Oscillator
  • CYCC 8.31
  • GCTS 1.37

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: